Amanote Research

Amanote Research

    RegisterSign In

Discover open access scientific publications

Search, annotate, share and cite publications


Publications by Giovanni Barosi

JAK Inhibition With Ruxolitinib Versus Best Available Therapy for Myelofibrosis

New England Journal of Medicine
Medicine
2012English

Addressing and Proposing Solutions for Unmet Clinical Needs in the Management of Myeloproliferative Neoplasm-Associated Thrombosis: A Consensus-Based Position Paper

Blood Cancer Journal
OncologyHematology
2019English

Role of TGF-β1/miR-382-5p/SOD2 Axis in the Induction of Oxidative Stress in CD34+ Cells From Primary Myelofibrosis

Molecular Oncology
Cancer ResearchMedicineOncologyGeneticsMolecular Medicine
2018English

Critical Appraisal of the Role of Ruxolitinib in Myeloproliferative Neoplasm-Associated Myelofibrosis

OncoTargets and Therapy
OncologyPharmacology
2015English

Activation of Non-Canonical TGF-β1 Signaling Indicates an Autoimmune Mechanism for Bone Marrow Fibrosis in Primary Myelofibrosis

Blood Cells, Molecules, and Diseases
Molecular MedicineHematologyMolecular BiologyCell Biology
2015English

Circulating CD34+, CD133+, and Vascular Endothelial Growth Factor Receptor 2–Positive Endothelial Progenitor Cells in Myelofibrosis With Myeloid Metaplasia

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2005English

The Constitutive Mobilization of Bone Marrow-Repopulating Cells Into the Peripheral Blood in Idiopathic Myelofibrosis

Blood
BiochemistryImmunologyCell BiologyHematology
2005English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy